Bortezomib 63323-0821
Product NDC
63323-0821- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 2, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209659
Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bortezomib | 3.5 mg/1 |
Drug Class
Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (63323-821-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE